Catherine Hays
Catherine Hays
Accelerating the Commercialization of Cancer Research Results
The Canadian Cancer Society (CCS) and the Creative Destruction Lab (CDL) have launched a new world-class accelerator program for entrepreneurs and researchers developing innovations to improve the cancer experience globally and throughout the cancer care continuum. This program will educate, coach, finance and inspire seed-stage oncology-focused companies by pairing them with mentors, industry leaders and subject matter experts. Over 9 months and 5 sessions, accepted startups will be supporte... Read More »
CCRA Welcomes New Patient/Family Representatives
Effective January 1st, 2025, the CCRA Advisory Board welcomes two new patient and family representatives, Adrienne Co-Dyre and Chantale Thurston, both well known cancer research advocates. Adrienne has used her accumulated knowledge and experience to inspire ch... Read More »
Effective January 1st, 2025, the CCRA Advisory Board welcomes two new patient and family representatives, Adrienne Co-Dyre and Chantale Thurston, both well known cancer research advocates. Adrienne has used her accumulated knowledge and experience to inspire ch... Read More »